Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction

被引：0
|
作者：
Stegmann, T. [1 ]
Parentin, L. [2 ]
Schirmer, S. H. [3 ]
Hagendorff, A. [2 ]
Laufs, U. [2 ]
Lavall, D. [2 ]
机构：
[1] Populat Hlth Res Inst, Hamilton, ON, Canada
[2] Leipzig Univ Hosp, Clin & Policlin Cardiol, Leipzig, Germany
[3] Univ Hosp Saarland UKS, KardioPraxis Kaiserslautern, Homburg, Germany
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ventricular-arterial coupling has independent prognostic value in patients with arterial hypertension and heart failure with reduced ejection fraction
    Akhmetov, R.
    Villevalde, S.
    Moiseev, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 289 - 290
  • [32] PARAMETERS OF VENTRICULAR-ARTERIAL COUPLING AND THEIR PROGNOSTIC VALUE IN STABLE PATIENTS WITH ARTERIAL HYPERTENSION AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Tyukhmenev, Evgeny
    Akhmetov, Roman
    Villevalde, Svetlana
    Kobalava, Zhanna
    JOURNAL OF HYPERTENSION, 2016, 34 : E263 - E263
  • [33] Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction
    Stegmann, Tina
    Parentin, Luisa
    Schirmer, Stephan H.
    Lavall, Philipp
    Hagendorff, Andreas
    Laufs, Ulrich
    Lavall, Daniel
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (06): : H1477 - H1489
  • [34] Ventricular-arterial coupling is associated with NT-proBNP in stable patients with heart failure and reduced ejection fraction
    Akhmetov, R.
    Villevalde, S.
    Safarova, A.
    Moiseev, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S323 - S323
  • [35] Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
    Mohebi, Reza
    Liu, Yuxi
    Felker, G. Michael
    Prescott, Margaret F.
    Ward, Jonathan H.
    Pina, Ileana L.
    Butler, Javed
    Solomon, Scott D.
    Januzzi, James L.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1673 - 1682
  • [36] Treatment of Heart Failure with Sacubitril/Valsartan in Hondurans with Reduced Left Ventricular Ejection Fraction: A Three-Year Experience
    Somoza Alvarenga, Francisco Ramon
    Amaya Handal, Ramses Daniel
    Alas Pineda, Cesar Ulises
    Mejia Raudales, Beatriz
    Toledo Martinez, Juan Fernando
    Gabriel Trejo, Isaac
    Jose Somoza, Francisco
    Martinez Schweinfurth, Ramon Alberto
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2021, 15 (04) : 137 - 142
  • [37] ECHOCARDIOGRAPHIC CHANGES AFTER SACUBITRIL/VALSARTAN TREATMENT IN HEART FAILURE OUTPATIENTS WITH REDUCED EJECTION FRACTION
    Gioia, M.
    Albanese, M.
    Parisi, G.
    Lisi, F.
    Amato, L.
    Urso, R.
    Angelini, G.
    Bellino, I.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G152 - G153
  • [38] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
  • [39] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION IN SINGAPORE
    Declan, L.
    Tang, Z. X.
    Ng, C.
    Tan, J.
    Trueman, D.
    Woodcock, F.
    Cristino, J.
    VALUE IN HEALTH, 2018, 21 : S106 - S106
  • [40] Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pere Pericas
    Caterina Mas-Lladó
    Maria Francisca Ramis-Barceló
    Isabel Valadrón
    Marta Noris Mora
    Lucía Pasamar Márquez
    Rosa González Colino
    José Francisco Forteza Albertí
    Vicente Peral Disdier
    Xavier Rossello
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 167 - 175
12345